| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8a143113a8426bd57def2ea84d70df56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7e061ab7c5fd963343dd16c6ced767f7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fd5224d6977055dc2b1a351e9548dae2 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16B15-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16C20-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16B15-30 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16B15-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G06F17-50 |
| filingDate |
2006-02-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7dbcb30c2d2f1574d4b3970a1e43646c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dd426b4d0bef369be5b9843e9353e433 |
| publicationDate |
2007-03-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2006084471-A3 |
| titleOfInvention |
Method of rational drug design based on binding ability with elongation factor tu |
| abstract |
The invention relates to a method of rational drug design based upon the surprising discovery that the structurally very different antibiotics enacyloxin Ha and kirromycin bind with Elongation Factor Tu (EF-Tu) in a similar manner. This allows for new chemical entities and new antibiotics to be developed. The invention defines a method for designing new antibiotics which are structural hybrids of enacyloxin IIa and kirromycin; the new antibiotics combining critical moieties of each of the parent molecules. |
| priorityDate |
2005-02-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |